Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program
Status:
No longer available
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to provide entecavir to subjects with chronic
Hepatitis B infection who have failed or who have demonstrated intolerance of marketed
therapies or for those in whom use of these agents is contraindicated and that have no other
available treatment options.